A novel compound heterozygous NBAS variant with HLH and multisystem involvement: expanding the clinical spectrum and literature review - Top-Institutions - MDSpire

A novel compound heterozygous NBAS variant with HLH and multisystem involvement: expanding the clinical spectrum and literature review

By
Xiaozhen Gong
Ye Feng
Qianlu Zhang
Lin Tong
Zijuan Feng
Xiaodong Zhao
Lina Zhou
Ying Dou
June 1, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

#1

Children’s Hospital of Chongqing Medical University

Chongqing, China
Key Differentiators
- Genetics
#2

MyGenostics

Beijing, China
Key Differentiators
- Genetics
#3

Massachusetts General Hospital

Boston, Massachusetts
Key Differentiators
- Genetics
#4

Erasmus MC

Rotterdam, Netherlands
Key Differentiators
- Genetics
#5

Osaka-City General Hospital

Osaka, Japan
Key Differentiators
- Genetics

Original Source(s)

Frontiers In Immunology

A novel compound heterozygous NBAS variant with HLH and multisystem involvement: expanding the clinical spectrum and literature review

by Xiaozhen Gong, Ye Feng, Qianlu Zhang, Lin Tong, Zijuan Feng, Xiaodong Zhao, Lina Zhou, Ying Dou
June 1, 2026

Related Content

Jmir Medical Informatics

Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis

Frontiers In Oncology

Silencing TMED2 suppresses cell growth and tumor progression in diffuse large B-cell lymphoma via inducing G0/G1 cell cycle arrest

by Wei Qian, Mingzhen Yang
May 1, 2026

The Medicine Maker

Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda

New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included

April 9, 2026
2 min